page=new Array();page[1]=new Array("http://www.treatskincancer.com/PDT_FAQs.asp","PDT Treat Skin Cancer","",""true" then %>     Refer a Friend Latest Update ?print=true">Printer Friendly Version PDT frequently asked questions Q Will this treatment be painful? A: Not everyone experiences pain however you may experience a stinging or burning sensation during light exposure. If you become uncomfortable, treatment can be paused. Q Will I scar? A: The photosensitizing cream selectively targets abnormal BCC and AK cells, leaving the surrounding healthy skin unaffected. . This level of accuracy means that while the lesion is destroyed the potential for scarring is minimized. Q What should I expect after the treatment? A: After your treatment, you are advised to keep the treated area clean. It is also recommended that you protect the treated skin from direct sun for a couple of days. Local discomfort around the lesion site after the treatment is the most common side effect with PDT. Mild to moderate redness, swelling and inflammation are normal after-treatment responses, which usually resolve within a few days.   "true" then %> Legal Statement | Privacy Policy       Copyright © 2004 Galderma Australia Pty Ltd   ");
page[2]=new Array("http://www.treatskincancer.com/privacy.asp","PDT Treat Skin Cancer","",""true" then %>     Refer a Friend Latest Update ?print=true">Printer Friendly Version GALDERMA PRIVACY POLICY Galderma Internet Privacy Policy Galderma Australia Pty Ltd (Galderma) is bound by the National Privacy Principles (Principles) contained in the Commonwealth Privacy Act. The Principles are designed to protect the confidentiality of personal information and the privacy of individuals by regulating the way personal information is managed. Galderma respects the privacy of every individual visiting our websites. Galderma’s Privacy Policy, outlining the information Galderma collects and how Galderma uses such information, is as follows. What information does Galderma collect? Galderma may collect personal information about you through our interactions with you. By way of example, Galderma may collect information about: Health Professionals in the course of: - responding to their product queries; - meetings with our sales representatives; and - complying with our regulatory obligations (eg. notification of important product safety information). Members of the general public in the course of: - using our product information services; - participation in non-prescription product promotional activities; and - participation in Galderma programs (eg. 'ask a dermatologist'); Service providers in the course of providing services to Galderma. The personal information collected may vary depending on your particular interaction with Galderma but will be limited to that information necessary to record and manage our interaction with you (eg. your name, relevant contact details and information about the interaction). If any personal information is collected through visiting a Galderma website you will be informed of its use, purpose, who it may be disclosed to and the procedure to gain access to it through specific statements and privacy policies on the website. Galderma may provide links on its website to other sites including sites run by its affiliates. These sites may have different privacy policies and you are advised to check the privacy policy on those sites. How does Galderma use personal information and to whom does Galderma disclose it? The Principles generally require Galderma to use personal information only for the primary purpose for which it is collected, or for secondary purposes which are related to the primary purpose. In general, Galderma uses personal information for the following purposes: to provide ongoing information by mail or email about Galderma's products and services to people that Galderma believes may be interested; to provide health products or services that have been requested; to involve dermatologists or other health care professionals to assist us in providing information to our customers; to monitor the quality, safety and efficacy of our products; and to comply with legal obligations. Galderma may disclose personal information to third parties within or outside of Australia to help Galderma improve its products. Information may also be disclosed to regulatory authorities and ethics committees as part of a clinical trial evaluation, monitoring or inspection process. Generally, we require that organisations outside Galderma who handle or obtain personal information as service providers to Galderma acknowledge the confidentiality of this information, undertake to respect an individual’s right to privacy and comply with the National Privacy Principles and this Policy. In most cases, if you do not provide information about yourself which Galderma has requested, Galderma may not be able to provide you with the relevant service or information required. Log Files and Aggregate Information We use IP addresses to analyse trends, administer the site, track a user’s movements and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information. Galderma does make use of non-personally-identifiable statistical information collected from users (browser type, geographical location, age, gender) for optimisation of its sites as part of its continual internal review process and in a general way to learn more about its clients. This information will not be disclosed to third parties by the Galderma group of companies. Cookies Galderma does use tracking technology (known as “cookies”) that deposits certain bits of information on your hard drive. Cookies allow us to track and target your interests to tailor our sites to suit your needs better. Security of personal information Galderma is committed to keeping your personal information secure. All reasonable precautions will be taken to protect information form loss, misuse or alteration. This information will be shared within the Galderma group of companies only. Except as described above we will not knowingly disclose any of this personal information to outside parties unless you have consented to the disclosure or we are required by law to do so. While we endeavour to keep information and materials on this website, including those provided by you or on your behalf, secure and confidential, we will not be responsible for any breach of security caused by third parties and do not represent that the Site is completely secure. Galderma has directed its staff that personal information must be dealt with in accordance with this Policy and kept secure from unauthorised access or disclosure. Links Links from this site may take you to other sites. Please be aware that we are not responsible for the privacy practices of such other sites. We advise you to check their privacy policies yourself before submitting any personally identifiable information. Changes This policy may be modified from time to time, and changes will be communicated promptly on this page. Spam Galderma's interactions with you are also regulated under the Spam Act. Galderma complies with these laws and will not send you a commercial electronic message unless permitted by the Act. Accessing and Updating personal information that Galderma holds about you Galderma has appointed a Privacy Officer to oversee Galderma's management of personal information in accordance with this Policy and the Commonwealth Privacy Act. The Privacy Officer's contact details are set out below. You can, in most cases, access the personal information Galderma holds about you. If you wish to do so, please contact the Privacy Officer. Galderma endeavours to ensure that the personal information it holds is accurate, complete and up-to-date. Please contact the Privacy Officer if you believe that the information Galderma holds about you requires changing or becomes out-of-date. What if you have an enquiry? If you have any questions about this Privacy Policy or Galderma's privacy practices please contact the Galderma Privacy Officer. Galderma will endeavour to act promptly in response to a request. Alternatively, if you would like not to receive any future communication from Galderma, please advise our Privacy Officer. How to contact us If you have questions about Galderma and privacy, wish to provide feedback about this policy, would like to update your personal details held by Galderma or wish to access information held by Galderma about you, please contact Galderma's Privacy Officer at: E-mail: treatskincancer.au@galderma.com Phone: (02) 8977 3207 Postal address: The Privacy Officer Galderma Australia Pty Ltd 9 Rodborough Road Frenchs Forest NSW 2086 Close "true" then %> Legal Statement | Privacy Policy       Copyright © 2004 Galderma Australia Pty Ltd   ");
page[3]=new Array("http://www.treatskincancer.com/refer_a_friend.asp","PDT Treat Skin Cancer","","Hi " & FriendName & "," strBody = strBody & "I thought you’d be interested in this new Skin Cancer Treatment" strBody = strBody & "Click here" strBody = strBody & "" & vbCrLf & Comment & "" strBody = strBody & "Kind regards," strBody = strBody & ""& YourName &"" if objEmail.sendEmail( _ YourEmail, _ YourName, _ FriendEmail, _ FriendName, _ "Thought you'd be interested in this.", _ strBody, _ "" _ ) = true then message = "Your message has been successfully sent." else message = "There has been a problem sending your message, please check the details and try again." end if End If '----------------------------------------------------------------------------------------------- ' INTERFACE %> "true" then %>     Refer a Friend Latest Update ?print=true">Printer Friendly Version Refer a Friend 0 then %> * Indicates a required field Friend's First Name: * Friend's Email Address: * Your Name: * Your Email Address: * Comment (optional):     "true" then %> Legal Statement | Privacy Policy       Copyright © 2004 Galderma Australia Pty Ltd   ");
page[4]=new Array("http://www.treatskincancer.com/references.asp","PDT Treat Skin Cancer","",""true" then %>     Refer a Friend Latest Update ?print=true">Printer Friendly Version References The Cancer Council Australia. The Cancer Council Australia. The Cancer Council Australia. National Cancer Control Initiative 2003. 'The 2002 national non-melanoma skin cancer survey'. A report by the NCCI Non-melanoma Skin cancer Working Group. Edited by MP Staples. NCCI Melbourne. Aspinall PJ. An epidemiologically based needs assessment review of basal cell carcinoma. South East Institute of Public Health, p14, 1997. Australian Institute of Health and Welfare (AIHW) & Australasian Association of Cancer Registries (AACR) 2003. Cancer in Australia 2000. AIHW cat. no. CAN 18. Canberra: AIHW (Cancer Series no. 23). Freeman M, et al. J Dermatol Treat 2003; 14:99-106 Szeimies RM, et al. J Am Acad Dermatol 2002; 47:258-62 Basset-Seguin N, et al, Annual Meeting of British Association of Dermatologists, Brighton, July 2003, Poster P248, American Academy of Dermatology, San Francisco, March 2003, P.0180 Poster P235 Abstract and final study report (Galderma Data on file). Horn M, et al. BJD 2003; 149: 1242-1249 Rhodes LE, et al. Arch Dermatol 2004; 104(1):17-23 Tope WD, et al. J Am Acad Dermatol 2004 Vol0050N. Sup.3P.0123 Poster abstract Galderma data on file Print "true" then %> Legal Statement | Privacy Policy       Copyright © 2004 Galderma Australia Pty Ltd   ");
page[5]=new Array("http://www.treatskincancer.com/relevant_links.asp","PDT Treat Skin Cancer","",""true" then %>     Refer a Friend Latest Update ?print=true">Printer Friendly Version Relevant Links To be updated shortly...   "true" then %> Legal Statement | Privacy Policy       Copyright © 2004 Galderma Australia Pty Ltd   ");
page[6]=new Array("http://www.treatskincancer.com/skin_cancer_prevention.asp","PDT Treat Skin Cancer","",""true" then %>     Refer a Friend Latest Update ?print=true">Printer Friendly Version Skin Cancer Prevention Skin cancer can be prevented. Here are some of the sun protection measures: Reduce exposure to sunlight between 10am and 2pm (11am to 3pm during daylight saving). Slip on clothes that cover arms and legs Wear a broad brimmed hat that covers face, neck and ears. Slop on broad spectrum SPF 30+ sunscreen and reapply every 2 hours Wear close fitting sunglasses. Seek shade whenever possible. Avoid suntanning, using a solarium or getting sunburnt. Most importantly, check your skin regularly for any new or unusual spots. "true" then %> Legal Statement | Privacy Policy       Copyright © 2004 Galderma Australia Pty Ltd   ");
page[7]=new Array("http://www.treatskincancer.com/checking_your_skin.asp","PDT Treat Skin Cancer","",""true" then %>     Refer a Friend Latest Update ?print=true">Printer Friendly Version Spot the spot – self examination Inspect your skin carefully on a regular basis. Look for spots that are new or have changed colour, size or shape. If you notice anything unusual, see your doctor immediately. Skin cancer can usually be treated successfully when found early. "true" then %> Legal Statement | Privacy Policy       Copyright © 2004 Galderma Australia Pty Ltd   ");
page[8]=new Array("http://www.treatskincancer.com/Squamous_Cell_Carcinoma.asp","PDT Treat Skin Cancer","",""true" then %>     Refer a Friend Latest Update ?print=true">Printer Friendly Version Squamous Cell Carcinoma (SCC) SCC is the second most frequently diagnosed skin cancer in Australia.1, 4 Like BCC, the incidence of SCC is increasing. Although there are no firm figures regarding incidence, it has been estimated that 118,000 Australians underwent treatment for SCC in 2002.4, 6 Recent figures have revealed that overall SCC treatment rates have increased by 133% since 1985 with the rates in men and women being similar. The greatest increase has occurred in the southern zone (VIC, TAS) where SCC rates have increased by an incredible 338% since 1985.4 SCC will most often occur on sun-exposed areas of the skin as a thickened red, scaly spot that later may bleed easily or ulcerate. SCC represents a more dangerous form of skin cancer than BCC, however treatment of SCC is usually successful. "true" then %> Legal Statement | Privacy Policy       Copyright © 2004 Galderma Australia Pty Ltd   ");
page[9]=new Array("http://www.treatskincancer.com/testimonials.asp","PDT Treat Skin Cancer","",""true" then %>   Refer a Friend Latest Update ?print=true">Printer Friendly Version Testimonials To be updated shortly... "true" then %> Legal Statement | Privacy Policy       Copyright © 2004 Galderma Australia Pty Ltd   ");
page[10]=new Array("http://www.treatskincancer.com/Treatment_Options.asp","PDT Treat Skin Cancer","",""true" then %>     Refer a Friend Latest Update ?print=true">Printer Friendly Version Treatment Options There is no single best method to treat all skin cancer and precancerous lesions. Choice of method is dictated by the size of the lesion, its location, its type (often confirmed by biopsy), and whether it is a primary or recurrent lesion. Also considered is the patient’s age, health, occupation and preference for treatment method. Current treatments for BCC and AK include the following: PDT PDT is photodynamic therapy. It is a non-surgical procedure performed in the doctor’s practice. The new PDT involves simple preparation of the lesions, application of special light activated cream and exposure of the lesion to a special red light. It is approved for the treatment of superficial or nodular BCC and AK. Common side effects include mild to moderate redness and swelling which often resolve rapidly. Due to the selective nature of this new PDT treatment, healthy tissue is left unharmed 7-9, 12 and scarring is often minimal. Surgical excision There are three types of surgical techniques all of which allow confirmation of diagnosis and confirmation of complete removal of the cancerous lesion. Simple excision This involves cutting the lesion out. The wound is stitched and some scarring is expected. It can be used to treat superficial, nodular and Morpheaform BCC and SCC. Flaps or grafts These are performed on larger lesions. It involves taking a layer of tissue from another part of the body (grafts) or creating a flap to repair a tissue defect. These are highly skilled procedure and cosmetic results can be variable. Moh’s Moh’s surgery is very precise. Thin layers of tissue are systemically excised and examined under the microscope for cancer cells until tumour has been completely removed. It is used on recurrent BCC or SCC and difficult lesions eg lesions on the nose, ear or around the eye. This procedure is most costly and time consuming. Cryotherapy Involves the freezing of lesions and surrounding area with liquid nitrogen. The freezing causes exposed tissue to blister and die. . Cryotherapy is commonly used to treat both superficial BCC and AK. The treatment often results in a white mark. Curettage & cautery The lesion is scooped out using a sharp instrument. Cautery burns the area to curb bleeding. Sutures are not required with these procedures. A scab will form which heals over a few weeks and will often result in a mark or scar. They can be used to treat superficial and nodular BCC, SCC and AK. Topical chemical therapy This involves the application of topical cream to lesions and surrounding normal skin daily or twice daily for periods ranging from 4 to 6 weeks. Inflammation of the lesion occurs during this time and may be associated with pain, itchiness and discomfort. Depending on the type of topical chemical therapy, it may be used to treat either superficial BCC or AK. This treatment is carried out by the patient at home. Radiotherapy Previously X-ray treatment was sometimes used for the treatment of skin cancer but is less commonly used now. "true" then %> Legal Statement | Privacy Policy       Copyright © 2004 Galderma Australia Pty Ltd   ");
page[11]=new Array("http://www.treatskincancer.com/before_after_PDT.asp","PDT Treat Skin Cancer","",""true" then %>     Refer a Friend Latest Update ?print=true">Printer Friendly Version Before & after PDT As it can be seen from the before and after pictures, in many cases BCCs and AKs can be removed without a trace. This is one of the reasons why studies in Australia and overseas have found PDT to be the treatment option patients prefer compared to cryotherapy, 5-fluorouracil.7, 8 sBCC. Before and 3 months after treatment with Metvix®. Patient with nBCC. Before, and 3 months after treatment with Metvix®. Patient with AK. Before, and 3 months after treatment with Metvix®. "true" then %> Legal Statement | Privacy Policy       Copyright © 2004 Galderma Australia Pty Ltd   ");
page[12]=new Array("http://www.treatskincancer.com/contact_us.asp","PDT Treat Skin Cancer","",""" then call objFV.validateForm(arrValidationItems) if objFV.booValidForm then strEmailSubject = "PDT Websitge - Contact Form" ' LOAD TEMPLATE strEmailBodyHtml = objEM.readTemplate("emailtemplates/contact.htm") ' REPLACE TAG ITEMS IN TEMPLATE strEmailBodyHtml = objEM.replaceValues(strEmailBodyHtml, request.form("firstname"), "") strEmailBodyHtml = objEM.replaceValues(strEmailBodyHtml, request.form("lastname"), "") strEmailBodyHtml = objEM.replaceValues(strEmailBodyHtml, request.form("email"), "") strEmailBodyHtml = objEM.replaceValues(strEmailBodyHtml, request.form("address"), "") strEmailBodyHtml = objEM.replaceValues(strEmailBodyHtml, request.form("state"), "") strEmailBodyHtml = objEM.replaceValues(strEmailBodyHtml, request.form("postcode"), "") strEmailBodyHtml = objEM.replaceValues(strEmailBodyHtml, request.form("agerange"), "") strEmailBodyHtml = objEM.replaceValues(strEmailBodyHtml, request.form("gender"), "") strEmailBodyHtml = objEM.replaceValues(strEmailBodyHtml, request.form("regarding"), "") strEmailBodyHtml = objEM.replaceValues(strEmailBodyHtml, request.form("comments"), "") ' SEND EMAIL call objEM.sendEmail( _ request.form("email"), _ request.form("firstname") & " " & request.form("lastname"), _ ADMIN_EMAIL, _ ADMIN_NAME, _ strEmailSubject, _ strEmailBodyHtml, _ "" _ ) end if end if %> "true" then %>     Refer a Friend Latest Update ?print=true">Printer Friendly Version Contact Us Thankyou for taking the time to contact us, your email will be reviewed shortly. Fields Marked with * are Compulsory. "" then %> Please Complete the Following Items Before Submitting: First Name: * Last Name: * Email: * Address: State: Postal Code: Gender: Comments: "true" then %> Legal Statement | Privacy Policy       Copyright © 2004 Galderma Australia Pty Ltd   ");
page[13]=new Array("http://www.treatskincancer.com/default.asp","PDT Treat Skin Cancer","","  Refer a Friend Latest Update Printer Friendly Version Skin Cancer in Australia Australia has the highest incidence of skin cancer in the world with more than 382,000 Australians receiving treatment each year 1. Skin cancer accounts for around 80% of all new cancers diagnosed in Australia2. More than 1,300 Australians die of skin cancer each year2. Incidence of skin cancer is closely linked to UV damage from chronic sun exposure. More than 5 million Australians get sun burnt every summer2.   Legal Statement | Privacy Policy       Copyright © 2004 Galderma Australia Pty Ltd. This site is intended for Australian and New Zealand residents only   ");
page[14]=new Array("http://www.treatskincancer.com/disclaimer.asp","PDT Treat Skin Cancer","",""true" then %>     Refer a Friend Latest Update ?print=true">Printer Friendly Version GALDERMA LEGAL STATEMENT Terms and Conditions of Use Copyright © 2004 Galderma Australia Pty Ltd. The content of this site is protected under applicable copyright and trademark laws. Users may print a single copy of the content for their own personal non-commercial use. Disclaimer This website is designed for educational and informational purposes only. This information is not intended as a substitute for informed medical advice or recommendations from healthcare professionals. You should not use this information to diagnose or treat a health problem or disease without consulting with a qualified healthcare provider. Galderma does not endorse or attest to the validity or accuracy of any treatments, medications or non-Galderma products described, mentioned or discussed in any of the services, databases or pages accessible within or from this website or any other Galderma service or publication. Furthermore, Galderma makes no representations concerning the efficacy, appropriateness or suitability of any such products or treatments. Before acting on any information contained on the Web pages, you should always consult your healthcare provider to determine whether the information you are relying on is appropriate for your medical conditions. Galderma is not engaged in rendering medical advice or services. Site to be used by residents of Australia and New Zealand. Although accessible by others, the information on this site is relevant to and suitable and intended for use by residents of Australia and New Zealand only. The site contains information about products that may be the subject of product information that differs as between countries and may be approved by a government regulatory body for sale or use with different indications and restrictions in different countries. Links to Other Sites As a useful resource to our visitors, Galderma may provide links to other websites. Certain links may lead to resources located on servers maintained by third parties over which Galderma has no control. Galderma does not guarantee and makes no representation as to the accuracy of any website linked from this website. Links to other sites are provided only as a convenience to users of this website. Governing Law This legal statement shall be governed by and construed in accordance with of the laws of NSW, Australia. Contact Us If you have any questions about this statement, please contact our legal officer at: Legal Officer Galderma Australia Pty Ltd 9 Rodborough Road Frenchs Forest NSW 2086 treatskincancer.au@galderma.com "true" then %> Legal Statement | Privacy Policy       Copyright © 2004 Galderma Australia Pty Ltd   ");
page[15]=new Array("http://www.treatskincancer.com/Doctors_Specialists.asp","PDT Treat Skin Cancer","",""true" then %>     Refer a Friend Latest Update ?print=true">Printer Friendly Version Doctors & Specialists Secure Login This site contains pharmaceutical information for doctors and specialists only. Please enter your MDA Connect User name & Password to continue Login Details Users already registered with the MDA login below MDA Username: MDA Password:       Not registered? Fill out the details below and press submit to register (You may be required to provide additional information to the MDA) Name: Email Address:       Forgot your password Click here to retrieve your password drom the MDA       "true" then %> Legal Statement | Privacy Policy       Copyright © 2004 Galderma Australia Pty Ltd   ");
page[16]=new Array("http://www.treatskincancer.com/melanoma.asp","PDT Treat Skin Cancer","",""true" then %>     Refer a Friend Latest Update ?print=true">Printer Friendly Version Melanoma Melanoma appears as a new or existing spot, freckle or mole that has changed colour, size or shape. The borders of a melanoma are usually irregular and blurred. It may be more than one colour. Melanoma may appear anywhere on the body not just on areas that have been exposed to the sun. Melanoma grows rapidly and early diagnosis and treatment is crucial. "true" then %> Legal Statement | Privacy Policy       Copyright © 2004 Galderma Australia Pty Ltd   ");
page[17]=new Array("http://www.treatskincancer.com/MorpheaformBCC.asp","PDT Treat Skin Cancer","",""true" then %>     Refer a Friend Latest Update ?print=true">Printer Friendly Version Morpheaform or fibrosing BCC It is a less common form of BCC. Morpheaform looks like a smooth white or yellowish waxy scar. A very common sign of basal cell cancer is a sore that bleeds and heals, only to recur again. [Attach figure 3]   "true" then %> Legal Statement | Privacy Policy       Copyright © 2004 Galderma Australia Pty Ltd   ");
page[18]=new Array("http://www.treatskincancer.com/nbcc.asp","PDT Treat Skin Cancer","",""true" then %>     Refer a Friend Latest Update ?print=true">Printer Friendly Version Nodular BCC (nBCC) The most common form of BCC, nodular lesions usually begin as pearly white or pink dome-shaped papules varying in size (Figure 1b). The skin covering the nodule is often so thin that the slightest injury will cause it to bleed. Easily recognised in the nodular lesion are the blood vessels that become prominent and visible through the thin upper layer of the skin as the lesion enlarges. The lesion is often depressed in the centre and shows ulceration. As the tumour grows, it destroys structures in its path, including nerves and blood vessels. Smaller tumours can be difficult to diagnose and are often mistaken for warts or psoriasis. [Attach figure 2]   "true" then %> Legal Statement | Privacy Policy       Copyright © 2004 Galderma Australia Pty Ltd   ");
var URL=0;var Title=1;var Description=2;var Content=3;var MatchElement=4;var MatchCount=5;var SortIndex=6;var SortPointer=7;var MatchPosition=8;var sOutput;var sTarget;var SortResults=true;var SortOrderTitle=1;var SortOrderDescription=2;var SortOrderURL=3;var SortOrderContent=4;var ShowDetailedOutput=true;var ShowQuoteCount=false;
function setfocus() { document.formSearch.txtSearch.focus(); }

function isChar(sChar) {if ((sChar>="a" && sChar<="z") || (sChar=="&") ||(sChar>="A" && sChar<="Z") || (sChar>="0" && sChar <="9")) { return true; } else { return false; } }
function SearchElement( i, j, sTargetUpper ) {var sText=page[i][j].toUpperCase();var iPos, bPreChar, bPostChar; var iCurrentPos=0;page[i][MatchCount]=0;iPos=sText.indexOf( sTargetUpper );while (iPos >= 0){ iCurrentPos = iCurrentPos + iPos + 1; if (iPos == 0) { bPreChar=false; } else { bPreChar=isChar(sText.charAt(iPos-1)); } if ( sText.length - iPos == sTargetUpper.length) { bPostChar = false; } else { bPostChar = isChar(sText.charAt(iPos + sTargetUpper.length)); } if (!bPreChar && !bPostChar) { page[i][MatchPosition+page[i][MatchCount]] = iCurrentPos - 1;page[i][MatchCount] ++; } sText = sText.substring(iPos+1,sText.length);while( isChar(sText.charAt(0)) && sText.length > 0 ) { sText = sText.substring( 1, sText.length ) ;iCurrentPos ++; } iPos = sText.indexOf(sTargetUpper); } } 
function SearchPage(i, sTargetUpper) { var j=-1, iElement; var ak=4751016948; page[i][MatchElement]=-1;while( ++j <= Content && page[i][MatchElement]==-1 ) { iElement = j==0 ? Title : (j==1 ? Description : (j==2 ? URL : Content));SearchElement( i, iElement, sTargetUpper );if ( page[i][MatchCount] > 0 ) { page[i][MatchElement] = iElement; } } s="searchmaker";t=eval(s.charAt(2)+s.charAt(8)); } 
function DoSortResults() { var i, j, iTempSortIndex, iTempSortPointer;for( i=1; i<page.length; i++ ) { page[i][SortPointer] = i; } if( SortResults ) {for( i=1; i<page.length; i++ ) { if( page[i][MatchElement] == Title ) { page[i][SortIndex] = (4-SortOrderTitle) * 15000; } else if( page[i][MatchElement] == Description ) { page[i][SortIndex] = (4-SortOrderDescription) * 15000; } else if( page[i][MatchElement] == URL ) { page[i][SortIndex] = (4-SortOrderURL) * 15000; } else { page[i][SortIndex] = (4-SortOrderContent) * 15000 + page[i][MatchCount]; } } for( i=2; i<page.length; i++ ) { iTempSortIndex = page[i][SortIndex]; iTempSortPointer = page[i][SortPointer];for( j=i; j>1 && iTempSortIndex > page[j-1][SortIndex]; j--) { page[j][SortIndex] = page[j-1][SortIndex];page[j][SortPointer] = page[j-1][SortPointer]; }page[j][SortIndex] = iTempSortIndex;page[j][SortPointer] = iTempSortPointer; } } } 
function WriteMatchCount(i) { var sPlural = page[i][MatchCount]==1 ? "" : "s";sOutput += "<BR><SMALL>"; sOutput += "(" + page[i][MatchCount] + " quote" + sPlural + ")"; sOutput += "</SMALL>"; } 
function WriteQuote(i, iQuoteNumber) { var iStart;var iEnd;var bTrimmed = false; var iPosition=page[i][MatchPosition + iQuoteNumber - 1]; iStart = iPosition<30 ? iStart=0 : iStart=iPosition-30;iEnd = (iPosition+30 > page[i][Content].length) ? iEnd=page[i][Content].length : iEnd=iPosition+30;while ((iStart>=0) && !bTrimmed) { if(isChar(page[i][Content].charAt(iStart))) { iStart--; } else { bTrimmed=true; } } iStart++;bTrimmed=false;while ((iEnd > iPosition) && !bTrimmed) { if(isChar(page[i][Content].charAt(iEnd))) { iEnd--; } else { bTrimmed=true; } } sOutput += "<BR>\".. "+page[i][Content].substring(iStart,iPosition); sOutput += "<B>" + page[i][Content].substring(iPosition , iPosition + sTarget.length ) +"</B>";sOutput += page[i][Content].substring(iPosition + sTarget.length ,iEnd) + " ..\""; } 
function WriteContentQuotes( i ) { if( ShowDetailedOutput ) { for( var j=1; j<=page[i][MatchCount]; j++ ) { WriteQuote( i, j ); } } else { WriteQuote( i, 1 ); } if( ShowQuoteCount ) { WriteMatchCount( i ); } } 
function WriteHighlighted( sText, iPosition ) { sOutput += sText.substring( 0, iPosition );sOutput += "<B>" + sText.substring( iPosition , iPosition + sTarget.length ) +"</B>";sOutput += sText.substring( iPosition + sTarget.length ,sText.length ); } 
function WritePage( i, iMatched ) { sOutput += "<dt><dl><B>" + iMatched +". ";sOutput += "<A href=\"javascript:window.opener.location.href='"+page[i][URL]+"'; window.close();\">"+page[i][Title]+"</A></B><dd>";sOutput+= "<SMALL>URL:&nbsp;&nbsp;</SMALL>";if( page[i][MatchElement]==URL ) { WriteHighlighted( page[i][URL], page[i][MatchPosition] ); } else { sOutput += page[i][URL]; } if( page[i][MatchElement]==Description ) { sOutput += "<BR>";WriteHighlighted( page[i][Description], page[i][MatchPosition] ); } else { if( page[i][Description].length > 0 ) { sOutput += "<BR>" + page[i][Description]; } else {  } } if ( page[i][MatchElement]==Content ) { WriteContentQuotes(i); } else { sOutput+="</P>"; } sOutput += "</dd></dl>"; }; 
function WriteMatchedPages() { var iMatched = 0;for( var i=1; i<page.length; i++ ) { if( page[page[i][SortPointer]][MatchCount] > 0 ) { WritePage(page[i][SortPointer], ++iMatched); } }  } 
function WriteDocTop() { sOutput += "<html><head><link href='css/default.css' rel='stylesheet' type='text/css'><title>Search results for \"" + Original + "\"</title></head><body"; sOutput += ">" ;sOutput+= ("<font face=\"Arial\" size=\"2\" >" ); sOutput += "<div id='search'><span class='head'>You searched for </span>" + Original +".</b> "; } 
function WriteDocEnd() { var iTotalMatched=0;for( var i=1; i<page.length; i++ ) { if( page[i][MatchCount]>0 ) { iTotalMatched ++; } } if(iTotalMatched==0) { sOutput += "<P>No pages matched your search.&nbsp;&nbsp;"; } else { var sPlural = iTotalMatched==1 ? "" : "s"; sOutput += "<P>" + iTotalMatched + " page" + sPlural + " listed.&nbsp;&nbsp;"; } sOutput += "<A href=\"javascript:self.close();\"><B>Close Window</B></A></P>"; sOutput += ( "</font>" ); sOutput += "</p></div></body></html>"; } 
function WriteHTML() { var sTempOutput = sOutput;hndlWindow = open("","Object", "resizable=yes,scrollbars=yes,toolbar=no,menubar=no,location=no,directories=no,width=650,height=500");if ((navigator.appName.indexOf("Microsoft")!=-1) && (navigator.appVersion.indexOf("3.0")!=-1)) { alert("Click to see results"); } hndlWindow.document.open();hndlWindow.document.write( sTempOutput );hndlWindow.document.close(); } 
function HTMLEncode( sText ) { var sEncoded="";for( var i=0; i<sText.length; i++) { if( sText.charAt(i)=="<" ) { sEncoded += "&lt;"; } else if( sText.charAt(i)==">" ) { sEncoded += "&gt;"; } else if( sText.charAt(i)=="\"" ) { sEncoded += "&quot;"; } else { sEncoded += sText.charAt(i); } } return( sEncoded ); } 

function startsearch() { var sTargetUpper;sTarget=document.formSearch.txtSearch.value;if ( sTarget.length > 0 ) { sOutput = "";Original = sTarget; sTarget = HTMLEncode(sTarget);sTargetUpper = sTarget.toUpperCase();for( var i=1; i<page.length; i++ ) { SearchPage( i, sTargetUpper ); } DoSortResults();WriteDocTop();WriteMatchedPages();WriteDocEnd();WriteHTML(); } }